BIO-Key International Inc BKYI.OQ BKYI.O is expected to show a fall in quarterly revenue when it reports results on November 14 for the period ending September 30 2024
The Holmdel New Jersey-based company is expected to report a 12.5% decrease in revenue to $1.6 million from $1.83 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for BIO-Key International Inc is for a loss of 58 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for BIO-Key International Inc is $3.00, above its last closing price of $1.05.
This summary was machine generated November 13 at 00:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments